Case study shows that site activation is a key driver in determining patient enrollment cycle time, which can be minimized by identifying the "sweet spot" of sites to deploy for a clinical trial.
Valerie Legagneur
Advertisement
Articles by Valerie Legagneur
Case study demonstrates that site activation is a key driver in determining patient enrollment cycle time.
Advertisement
Latest Updated Articles
Enrollment Cycle Times Can and Should Be OptimizedPublished: January 17th 2018 | Updated:
- Enrollment Cycle Times Can and Should Be Optimized
Published: January 17th 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NIH Implements Contingency Plan as Government Shutdown Impacts Research Funding
2
Focusing on Site Needs and Challenges: Quick Tips for Sponsors/CROs
3
AI in Action: Breaking Down Clinical Trial Bottlenecks
4
AI Everywhere: Architecting the Future of Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
